Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Steven D Ertel. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Steven D Ertel har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:XLRN / Acceleron Pharma Inc | EVP & Chief Operating Officer | 47 300 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Steven D Ertel. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Steven D Ertel som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 47 300 | 47 300 | |||||
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | −7 900 | 136 977 | −5,45 | ||||
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 900 | 129 077 | −1,45 | 27,61 | −52 459 | 3 563 816 |
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 130 977 | −0,46 | 26,92 | −16 152 | 3 525 901 |
| 2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −4 421 | 1 883 | −70,13 | ||||
| 2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 4 421 | 131 577 | 3,48 | 5,28 | 23 343 | 694 727 | |
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 966 | 6 304 | −38,62 | |||
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 127 156 | −0,39 | 34,13 | −17 065 | 4 339 834 |
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 466 | 127 656 | −2,64 | 32,89 | −113 997 | 4 198 606 |
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 966 | 131 122 | 3,12 | 5,28 | 20 940 | 692 324 |
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −18 095 | 10 270 | −63,79 | |||
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −10 209 | 0 | −100,00 | |||
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −28 304 | 127 156 | −18,21 | 34,77 | −984 130 | 4 421 214 |
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 18 095 | 155 460 | 13,17 | 5,28 | 95 542 | 820 829 |
| 2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 209 | 137 365 | 8,03 | 3,88 | 39 611 | 532 976 |
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −13 484 | 10 209 | −56,91 | |||
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 344 | 0 | −100,00 | |||
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −12 500 | 12 500 | −50,00 | |||
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 942 | 28 365 | −12,20 | |||
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −32 270 | 127 156 | −20,24 | 32,00 | −1 032 640 | 4 068 992 |
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 13 484 | 159 426 | 9,24 | 3,88 | 52 318 | 618 573 |
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 344 | 145 942 | 1,63 | 5,08 | 11 908 | 741 385 |
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 500 | 143 598 | 9,53 | 7,12 | 89 000 | 1 022 418 |
| 2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 942 | 131 098 | 3,10 | 5,28 | 20 814 | 692 197 |
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 45 000 | 45 000 | |||||
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 7 500 | 127 156 | 6,27 | ||||
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 32 307 | −5,83 | |||
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 119 656 | −1,64 | 33,61 | −67 220 | 4 021 638 |
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 121 656 | 1,67 | 5,28 | 10 560 | 642 344 |
| 2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 62 000 | 119 656 | 107,53 | ||||
| 2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 34 307 | −5,51 | |||
| 2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 57 656 | −3,35 | 30,46 | −60 920 | 1 756 202 |
| 2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 59 656 | 3,47 | 5,28 | 10 560 | 314 984 |
| 2015-07-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 193 | 36 307 | −3,18 | |||
| 2015-07-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −807 | 23 693 | −3,29 | |||
| 2015-07-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 57 656 | −3,35 | 31,38 | −62 760 | 1 809 245 |
| 2015-07-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 193 | 59 656 | 2,04 | 5,28 | 6 299 | 314 984 |
| 2015-07-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 807 | 58 463 | 1,40 | 3,88 | 3 131 | 226 836 |
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 24 500 | −7,55 | |||
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 57 656 | −3,35 | 31,11 | −62 220 | 1 793 678 |
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 59 656 | 3,47 | 3,88 | 7 760 | 231 465 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 26 500 | −7,02 | |||
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 285 | 57 656 | −2,18 | 31,59 | −40 593 | 1 821 353 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −715 | 58 941 | −1,20 | 31,32 | −22 394 | 1 846 032 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 59 656 | 3,47 | 3,88 | 7 760 | 231 465 |
| 2015-05-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −5 000 | 28 500 | −14,93 | ||||
| 2015-05-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 57 656 | 9,50 | 3,88 | 19 400 | 223 705 | |
| 2015-04-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 33 500 | −5,63 | |||
| 2015-04-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 52 656 | −3,66 | 33,58 | −67 160 | 1 768 188 |
| 2015-04-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 54 656 | 3,80 | 3,88 | 7 760 | 212 065 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 000 | 30 000 | |||||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 906 | 2 344 | −62,50 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 094 | 0 | −100,00 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 52 656 | −0,75 | 42,05 | −16 820 | 2 214 185 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 043 | 53 056 | −3,71 | 41,28 | −84 335 | 2 190 152 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 557 | 55 099 | −4,43 | 40,54 | −103 661 | 2 233 713 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 906 | 57 656 | 7,27 | 5,08 | 19 842 | 292 892 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 094 | 53 750 | 2,08 | 1,80 | 1 969 | 96 750 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 1 094 | −82,05 | |||
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 52 656 | −0,57 | 39,95 | −11 985 | 2 103 607 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 900 | 52 956 | −3,46 | 39,03 | −74 157 | 2 066 873 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 800 | 54 856 | −4,86 | 38,33 | −107 324 | 2 102 630 |
| 2015-02-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 57 656 | 9,50 | 1,80 | 9 000 | 103 781 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 000 | 35 500 | −5,33 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 52 656 | −0,38 | 41,05 | −8 210 | 2 161 529 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 800 | 52 856 | −3,29 | 40,53 | −72 954 | 2 142 254 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 54 656 | 3,80 | 3,88 | 7 760 | 212 065 |
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
| 2015-01-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 6 094 | −45,07 | |||
| 2015-01-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 52 656 | −1,31 | 39,36 | −27 552 | 2 072 540 |
| 2015-01-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 300 | 53 356 | −7,46 | 38,32 | −164 776 | 2 044 602 |
| 2015-01-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 57 656 | 9,50 | 1,80 | 9 000 | 103 781 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 500 | 6 250 | −28,57 | |||
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 969 | 11 094 | −21,11 | |||
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 031 | 0 | −100,00 | |||
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 52 656 | −1,31 | 37,41 | −26 187 | 1 969 861 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 53 356 | −1,11 | 36,16 | −21 696 | 1 929 353 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 200 | 53 956 | −2,18 | 34,89 | −41 868 | 1 882 525 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 55 156 | 4,75 | 5,08 | 12 700 | 280 192 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 300 | 52 656 | −2,41 | 37,27 | −48 451 | 1 962 489 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 100 | 53 956 | −2,00 | 36,24 | −39 864 | 1 955 365 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 600 | 55 056 | −4,51 | 34,97 | −90 922 | 1 925 308 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 969 | 57 656 | 5,43 | 1,80 | 5 344 | 103 781 |
| 2014-12-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 031 | 54 687 | 3,86 | 0,92 | 1 869 | 50 312 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 8 750 | −36,36 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −313 | 2 031 | −13,35 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 687 | 0 | −100,00 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 964 | 52 656 | −5,33 | 33,60 | −99 590 | 1 769 242 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 036 | 55 620 | −3,53 | 32,45 | −66 068 | 1 804 869 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 57 656 | 9,50 | 5,08 | 25 400 | 292 892 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 935 | 52 656 | −5,28 | 33,62 | −98 675 | 1 770 295 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 065 | 55 591 | −3,58 | 32,48 | −67 071 | 1 805 596 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 313 | 57 656 | 0,55 | 0,92 | 288 | 53 044 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 687 | 57 343 | 8,90 | 0,92 | 4 312 | 52 756 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 000 | 13 750 | −26,67 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 125 | 4 687 | −40,00 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 875 | 0 | −100,00 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −900 | 52 656 | −1,68 | 30,28 | −27 252 | 1 594 424 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 100 | 53 556 | −7,11 | 29,53 | −121 073 | 1 581 509 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 57 656 | 9,50 | 5,08 | 25 400 | 292 892 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 52 656 | −1,50 | 30,27 | −24 216 | 1 593 897 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 200 | 53 456 | −7,28 | 29,53 | −124 026 | 1 578 556 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 125 | 57 656 | 5,73 | 0,92 | 2 875 | 53 044 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 875 | 54 531 | 3,56 | 0,40 | 750 | 21 812 |
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 500 | 1 875 | −57,14 | |||
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 500 | 18 750 | −28,57 | |||
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 500 | 52 656 | −4,53 | 26,43 | −66 075 | 1 391 698 |
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 55 156 | 4,75 | 0,40 | 1 000 | 22 062 |
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 500 | 52 656 | −12,47 | 26,44 | −198 300 | 1 392 225 |
| 2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 500 | 60 156 | 14,24 | 5,08 | 38 100 | 305 592 |
| 2014-08-26 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −9 000 | 37 500 | −19,35 | ||||
| 2014-08-26 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 9 000 | 52 656 | 20,62 | 3,88 | 34 920 | 204 305 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 500 | 26 250 | −22,22 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 500 | 4 375 | −36,36 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 43 656 | −0,23 | 30,37 | −3 037 | 1 325 833 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 400 | 43 756 | −14,47 | 29,77 | −220 298 | 1 302 616 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 500 | 51 156 | 17,18 | 5,08 | 38 100 | 259 872 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 500 | 43 656 | −5,42 | 29,78 | −74 450 | 1 300 076 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 46 156 | 5,73 | 0,40 | 1 000 | 18 462 |
| 2014-08-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −8 000 | 46 500 | −14,68 | ||||
| 2014-08-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 8 000 | 43 656 | 22,44 | 3,88 | 31 040 | 169 385 | |
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 500 | 6 875 | −26,67 | |||
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 500 | 33 750 | −18,18 | |||
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 500 | 35 656 | −6,55 | 34,10 | −85 250 | 1 215 870 |
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 38 156 | 7,01 | 0,40 | 1 000 | 15 262 |
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 500 | 35 656 | −17,38 | 34,09 | −255 675 | 1 215 513 |
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 500 | 43 156 | 21,03 | 5,08 | 38 100 | 219 232 |
| 2014-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | −8 000 | 54 500 | −12,80 | ||||
| 2014-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 8 000 | 35 656 | 28,93 | 3,88 | 31 040 | 138 345 | |
| 2014-06-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 500 | 9 375 | −21,05 | |||
| 2014-06-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 500 | 41 250 | −15,38 | |||
| 2014-06-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | 2 500 | 27 656 | 9,94 | 29,73 | 74 325 | 822 213 |
| 2014-06-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 30 156 | 9,04 | 0,40 | 1 000 | 12 062 |
| 2014-06-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 27 656 | −0,72 | 30,04 | −6 008 | 830 786 |
| 2014-06-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 300 | 27 856 | −20,76 | 29,71 | −216 883 | 827 602 |
| 2014-06-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 500 | 35 156 | 27,12 | 5,08 | 38 100 | 178 592 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −7 500 | 48 750 | −13,33 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 500 | 11 875 | −17,39 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −391 | 27 656 | −1,39 | 32,19 | −12 586 | 890 247 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −7 109 | 28 047 | −20,22 | 31,48 | −223 791 | 882 920 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 500 | 35 156 | 27,12 | 5,08 | 38 100 | 178 592 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 27 656 | −0,36 | 32,35 | −3 235 | 894 672 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 400 | 27 756 | −7,96 | 31,49 | −75 576 | 874 036 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 30 156 | 9,04 | 0,40 | 1 000 | 12 062 |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | 2 500 | 14 375 | 21,05 | |||
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 27 656 | −2,47 | 36,17 | −25 319 | 1 000 318 |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 800 | 28 356 | −5,97 | 35,75 | −64 350 | 1 013 727 |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 30 156 | 9,04 | 0,40 | 1 000 | 12 062 |
| 2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 | |||||
| 2013-09-18 | 3 | XLRN |
ACCELERON PHARMA INC
Common Stock |
27 656 |